Airrane Co., Ltd. (KOSDAQ:163280)
17,910
+170 (0.96%)
Last updated: Aug 7, 2025
Sage Therapeutics Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 29,714 | 32,579 | 15,984 | 8,732 | 9,825 |
Short-Term Investments | 397.53 | 433.65 | 108 | 120.23 | 26.05 |
Trading Asset Securities | 2,000 | - | 27.8 | 26.44 | - |
Cash & Short-Term Investments | 32,111 | 33,013 | 16,120 | 8,879 | 9,851 |
Cash Growth | 99.20% | 104.79% | 81.55% | -9.87% | - |
Accounts Receivable | 4,104 | 4,066 | 1,621 | 1,768 | 4,710 |
Other Receivables | 180.11 | 74.34 | 157.82 | 195.64 | 19.56 |
Receivables | 5,377 | 5,233 | 1,907 | 2,092 | 4,893 |
Inventory | 7,132 | 5,257 | 4,033 | 3,060 | 2,241 |
Prepaid Expenses | 1,145 | 1,268 | 927.68 | 353.89 | 136 |
Other Current Assets | 4,454 | 3,923 | 617.62 | - | 168.84 |
Total Current Assets | 50,219 | 48,693 | 23,605 | 14,385 | 17,290 |
Property, Plant & Equipment | 25,658 | 25,779 | 18,143 | 13,917 | 4,137 |
Long-Term Investments | - | 0 | -0 | - | 150 |
Other Intangible Assets | 964.94 | 1,009 | 1,176 | 912.58 | 160.95 |
Long-Term Deferred Tax Assets | 1,733 | 1,602 | 1,533 | 2,340 | - |
Long-Term Deferred Charges | - | - | - | - | 0.01 |
Other Long-Term Assets | 5,373 | 5,346 | 765.63 | 654.45 | 425.78 |
Total Assets | 83,954 | 82,435 | 45,223 | 32,209 | 22,164 |
Accounts Payable | 1,340 | 1,717 | 658.51 | 353.33 | 495.03 |
Accrued Expenses | 644.11 | 655.32 | 175.86 | 271.79 | 161.44 |
Short-Term Debt | 6,300 | 6,300 | 1,440 | 2,666 | 2,231 |
Current Portion of Long-Term Debt | 250 | 175 | - | 674.54 | - |
Current Portion of Leases | 63.8 | 74.91 | 90.3 | 68.32 | - |
Current Income Taxes Payable | 742.24 | 578.78 | 643.75 | 221.77 | 0.01 |
Current Unearned Revenue | - | - | - | 1,142 | - |
Other Current Liabilities | 5,989 | 5,641 | 5,061 | 260.88 | 47.49 |
Total Current Liabilities | 15,330 | 15,143 | 8,070 | 5,659 | 2,935 |
Long-Term Debt | 1,713 | 1,788 | 1,600 | 17,434 | 6,778 |
Long-Term Leases | 65.43 | 77.33 | 129.86 | 59.11 | - |
Other Long-Term Liabilities | 73.1 | 73.1 | 225.58 | 18,310 | 149.88 |
Total Liabilities | 18,591 | 18,429 | 11,132 | 42,042 | 10,295 |
Common Stock | 817.48 | 817.48 | 706.15 | 350 | 350 |
Additional Paid-In Capital | 84,969 | 84,969 | 58,486 | 705.65 | 705.65 |
Retained Earnings | -21,713 | -22,735 | -24,568 | -9,330 | 2,591 |
Treasury Stock | -1,431 | -1,431 | -1,559 | -1,559 | -1,559 |
Comprehensive Income & Other | 2,721 | 2,386 | 1,026 | 0 | 780.51 |
Total Common Equity | 65,363 | 64,006 | 34,091 | -9,833 | 2,868 |
Shareholders' Equity | 65,363 | 64,006 | 34,091 | -9,833 | 11,868 |
Total Liabilities & Equity | 83,954 | 82,435 | 45,223 | 32,209 | 22,164 |
Total Debt | 8,392 | 8,415 | 3,260 | 20,902 | 9,010 |
Net Cash (Debt) | 23,719 | 24,597 | 12,860 | -12,023 | 841.33 |
Net Cash Growth | 84.44% | 91.27% | - | - | - |
Net Cash Per Share | 3487.26 | 4198.39 | 5409.77 | -5653.21 | - |
Filing Date Shares Outstanding | 6.8 | 6.8 | 5.69 | 2.13 | - |
Total Common Shares Outstanding | 6.8 | 6.8 | 5.69 | 2.13 | - |
Working Capital | 34,889 | 33,551 | 15,536 | 8,726 | 14,355 |
Book Value Per Share | 9610.08 | 9410.56 | 5993.24 | -4623.51 | - |
Tangible Book Value | 64,398 | 62,998 | 32,915 | -10,746 | 2,708 |
Tangible Book Value Per Share | 9468.21 | 9262.27 | 5786.49 | -5052.60 | - |
Land | 9,466 | 9,466 | 8,196 | 7,973 | 1,460 |
Buildings | 6,778 | 6,752 | 4,581 | 3,826 | 1,330 |
Machinery | 12,491 | 11,897 | 7,975 | 8,414 | 5,478 |
Construction In Progress | 499.21 | 565.22 | 2,078 | 633.59 | 1,324 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.